Oral liquid formulations of lipid-lowering and blood pressure-lowering drugs
US12377045B2 · kind B2 · utility
0Cited by
0References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 24, 2020 |
| Grant date | Aug 5, 2025 |
| Priority date | — |
| Expiry date | Jul 21, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This application discloses oral liquid formulations of lipid/cholesterol-lowering drugs and blood pressure-lowering drugs, and combinations thereof, comprising surfactant(s) as stabilizer(s), which forms micelles with the drug molecules to enhance their solubility and stability.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.